open image in gallery Semaglutide - the active ingredient in Ozempic and other Novo products - has been linked to eye conditions (Getty/iStock) In subgroup analyses, the elevated risk for NAION ...

A new international study reveals a possible connection between GLP1 receptor agonists—used in drugs like Ozempic—and ...

A North Carolina woman has filed a lawsuit in New Jersey federal court, claiming that her use of the diabetes medication Ozempic led to permanent vision loss. Elizabeth Pennell alleges that Novo ...

A new study suggests that two widely used Type 2 diabetes medications—GLP-1 receptor agonists and SGLT2 inhibitors—may help reduce the risk of Alzheimer’s disease and related dementias.

Certain foods can worsen GI side effects from GLP-1 durgs. Learn which foods to avoid and which to choose instead.

The drugmaker Lilly announced topline results of a clinical trial of a new pill in the same drug class as injectables like Ozempic.

These included GLP-1 receptor agonists like Ozempic (which promote insulin ... significantly associated with decreased risk of Alzheimer's disease and related dementias compared with other glucose ...

It’s hard to keep up with all of the potential perks of going on a GLP-1 receptor agonist medication like Ozempic ... may help reduce the risk of cardiovascular disease and colorectal cancer ...

Not one but two new studies published today have linked GLP-1 drugs like Ozempic to a decreased ... associated with a decreased risk of Alzheimer’s disease and related dementias,” said Dr ...

like Ozempic, like Mounjaro, may reduce the risk of dementia in people who are on those drugs," Dr. Céline Gounder, CBS News medical contributor and editor-at-large for public health at KFF ...